Novel Mutations in the Nonselective Sodium Leak Channel (NALCN) Lead to Distal Arthrogryposis with Increased Muscle Tone

Abstract

Distal arthrogryposis (DA) is a feature in genetically and clinically heterogeneous groups of disorders. Mostly myopathic and neurogenic defects have been described, but many patients remain without genetic diagnosis. We are elaborating on the clinical presentation of neonatal cases with DA who carry novel mutations in the nonselective sodium leak channel (NALCN). Two patients reported herein were remarkable for central hypertonicity in addition to DA. By trio-whole exome sequencing, two undescribed de novo mutations in NALCN were revealed. Both mutations (p.F317C and p.V595F) are located on pore-forming segments of NALCN. Dominant NALCN mutations in the pore-forming segments have been identified in similar patients, whereas recessive mutations outside the pore-forming segments result in different phenotypes. Our findings with central hypertonia broaden the phenotypic spectrum of de novo mutations in the pore-forming segments of NALCN. Recent findings of successful acetazolamide treatment in patients with channelopathies might point to potential therapies based on the ion channel similarities and the location of the mutation.

Keywords

distal arthrogryposis - central hypertonia - de novo - NALCN - sodium leak channel

• References

• 1 Chong JX, McMillin MJ, Shively KM , et al; University of Washington Center for Mendelian Genomics. De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay. Am J Hum Genet 2015; 96 (3) 462-473
• 2 McMillin MJ, Beck AE, Chong JX , et al; University of Washington Center for Mendelian Genomics. Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5. Am J Hum Genet 2014; 94 (5) 734-744
• 3 Beck AE, McMillin MJ, Gildersleeve HI, Shively KM, Tang A, Bamshad MJ. Genotype-phenotype relationships in Freeman-Sheldon syndrome. Am J Med Genet A 2014; 164A (11) 2808-2813
• 4 Zhu X, Petrovski S, Xie P , et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med 2015; 17 (10) 774-781
• 5 Herholz J, Meloni A, Marongiu M , et al. Differential secretion of the mutated protein is a major component affecting phenotypic severity in CRLF1-associated disorders. Eur J Hum Genet 2011; 19 (5) 525-533
• 6 Köroğlu Ç, Seven M, Tolun A. Recessive truncating NALCN mutation in infantile neuroaxonal dystrophy with facial dysmorphism. J Med Genet 2013; 50 (8) 515-520
• 7 Al-Sayed MD, Al-Zaidan H, Albakheet A , et al. Mutations in NALCN cause an autosomal-recessive syndrome with severe hypotonia, speech impairment, and cognitive delay. Am J Hum Genet 2013; 93 (4) 721-726
• 8 Aoyagi K, Rossignol E, Hamdan FF , et al. A gain-of-function mutation in NALCN in a child with intellectual disability, ataxia and arthrogryposis. Hum Mutat 2015; 36 (8) 753-757
• 9 Matthews E, Portaro S, Ke Q , et al. Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology 2011; 77 (22) 1960-1964
• 10 Ren D. Sodium leak channels in neuronal excitability and rhythmic behaviors. Neuron 2011; 72 (6) 899-911
• 11 Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TP. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol 2004; 56 (2) 213-220
• 12 Lu B, Su Y, Das S, Liu J, Xia J, Ren D. The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm. Cell 2007; 129 (2) 371-383